May 30, 2019 | Cost Savings, MedBen Rx, Pharmacy Benefits Manager (PBM), Prescription, Rebates, Transparency
The MedBen Rx approach to drug pricing is straightforward. We keep client costs low by reimbursing pharmacies what they pay for prescription drugs, plus a reasonable dispensing fee. By doing so, we ensure that self-funded employers get the maximum value from their...
May 19, 2019 | Announcements, Claims Management, Cost Savings, MedBen Rx Advocate, News, Prescription, Third party administration
MedBen medical and pharmacy claim costs rose only 0.4% per employee for clients in 2018, shattering national data norms that reported an average of 6% cost increases. Our pharmacy claim costs alone dropped 2.7% last year, due to the introduction our new program MedBen...
May 18, 2019 | Cost Savings, MedBen Rx, Prescription, Transparency
The Trump administration recently announced that drug makers will now have to include prices in their TV advertisingbeginning this summer. Prescription drug cost transparency is a good thing… and MedBen makes transparency a keystone of its pharmacy plans, so clients...
May 5, 2019 | Cost Savings, MedBen Rx, MedBen Rx Advocate, MedBen Rx Alliance, Prescription
In an era where employer pharmacy plans routinely face annual double-digit cost increases, MedBen clients are seeing things differently. Employers who utilized MedBen pharmacy solutions in their 2018 plans realized an average 2.7% decrease in per-member spending from...
Apr 21, 2019 | Alternative Plan Design, Cost Savings, Direct-to-Employer Contracting, MedBen University, Municipalities, Prescription
“In 2018, per-employee net claim costs for our municipality block decreased 4.9% from 2017,” announced MedBen Vice President of Sales & Marketing Brian Fargus at the 13th Annual Municipality Roundtable on April 11. This reduced cost factors both...
Apr 5, 2019 | Cost Savings, Prescription
The ongoing movement to reduce prescription drug spending focuses primarily on the cost factor. But as Shannon Brownlee and Judith Garber contend in a Stat opinion piece, overprescribing of drugs also carries financial and health risks. “Between 2000 and 2012,...
